Bangkok Genomics Innovation PCL (BKK:BKGI) Change In Payables And Accrued Expense : ฿16.4 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL Change In Payables And Accrued Expense?

Bangkok Genomics Innovation PCL's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ฿3.6 Mil. It means Bangkok Genomics Innovation PCL's Accounts Payable & Accrued Expense increased by ฿3.6 Mil from Dec. 2024 to Mar. 2025 .

Bangkok Genomics Innovation PCL's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ฿8.5 Mil. It means Bangkok Genomics Innovation PCL's Accounts Payable & Accrued Expense increased by ฿8.5 Mil from Dec. 2023 to Dec. 2024 .

Bangkok Genomics Innovation PCL Change In Payables And Accrued Expense Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL Change In Payables And Accrued Expense Chart

Bangkok Genomics Innovation PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

10.46

-8.06

-5.37

11.87

8.54

Bangkok Genomics Innovation PCL Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial									-4.28	20.82	-2.10	-5.90	3.57

Bangkok Genomics Innovation PCL Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿16.4 Mil.

Bangkok Genomics Innovation PCL Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bangkok Genomics Innovation PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110

Website

https://www.bangkokgenomics.com

Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.